Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate (Picato) in a Period of 8 Weeks.

NCT02090465 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT02090465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02090465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate (Picato) in a Period of 8 Weeks.
Lead sponsor
LEO Pharma
Phase
Observational
Overall status
Completed
Start date
July 31, 2013
Completion date
December 31, 2013
Enrollment
840 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis